RIL
BBNX

Rothschild Investment LLC’s Beta Bionics BBNX Stock Holding History

Rothschild Investment LLC’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66K Buy
106
+97
+1,078% +$1.15K ﹤0.01% 2836
2026
Q1 		$90 Sell
9
-8
-47% -$118 ﹤0.01% 3410
2025
Q4 		$518 Buy
17
+12
+240% +$320 ﹤0.01% 2915
2025
Q3 		$99 Buy
+5
New +$88 ﹤0.01% 3067

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Rothschild Investment LLC's BBNX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Beta Bionics (BBNX) stake by 1,078% in Q2 2026, buying an estimated $1.15K and bringing the position to 106 shares worth $1.66K. The position accounts for ﹤0.01% of the portfolio, ranked #2836.

Rothschild Investment LLC first reported a position in BBNX in Q3 2025 and has held it in 4 quarters since. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Rothschild Investment LLC held 106 shares of Beta Bionics worth $1.66K as of Q2 2026.
  • Rothschild Investment LLC bought 97 Beta Bionics shares in Q2 2026, an estimated $1.15K.
  • Beta Bionics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2836 holding.
  • Rothschild Investment LLC first reported a position in Beta Bionics in Q3 2025 and has held it in 4 quarters since.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.